SectorPharmaceutical
Established Date27/01/2014
Listing Date23/03/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees37
Fiscal Year Ends31/12
Security TypeCommon stock
Office address901 Gateway Boulevard, Third Floor, South San Francisco, CA 94080
Business
IntroductionCorvus Pharmaceuticals, Inc., was incorporated in Delaware on January 27, 2014. The company is a clinical-stage biopharmaceutical company that is developing product candidates for proteins that are critical to immune cell function. Its lead drug candidate, soquelitinib, is designed to inhibit ITK and is currently being evaluated in clinical trials for conditions including T-cell lymphoma and atopic dermatitis. The company's strategy focuses on applying its immunology expertise to multiple disease areas with significant unmet medical needs.
